Switch to:
Horizon Pharma PLC (NAS:HZNP)
EV/EBITDA
20.29 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Horizon Pharma PLC's enterprise value is $3,937.4 Mil. Horizon Pharma PLC's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2016 was $194.1 Mil. Therefore, Horizon Pharma PLC's EV/EBITDA ratio for today is 20.29.

HZNP' s EV/EBITDA Range Over the Past 10 Years
Min: -608   Max: 518
Current: 20.29

-608
518

During the past 8 years, the highest EV/EBITDA Ratio of Horizon Pharma PLC was 518.00. The lowest was -608.00. And the median was -0.40.

HZNP's EV/EBITDA is ranked lower than
57% of the 625 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 16.97 vs. HZNP: 20.29 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Horizon Pharma PLC's stock price is $19.85. Horizon Pharma PLC's earnings per share for the trailing twelve months (TTM) ended in Mar. 2016 was $0.09. Therefore, Horizon Pharma PLC's P/E Ratio for today is 225.57.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Horizon Pharma PLC's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=3937.423/194.054
=20.29

Horizon Pharma PLC's current Enterprise Value is $3,937.4 Mil.
Horizon Pharma PLC's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2016 was -0.765 (Jun. 2015 ) + 89.014 (Sep. 2015 ) + 82.367 (Dec. 2015 ) + 23.438 (Mar. 2016 ) = $194.1 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Horizon Pharma PLC's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=19.85/0.088
=225.57

Horizon Pharma PLC's share price for today is $19.85.
Horizon Pharma PLC's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2016 was 0.2 (Jun. 2015 ) + 0.02 (Sep. 2015 ) + 0.148 (Dec. 2015 ) + -0.28 (Mar. 2016 ) = $0.09.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Horizon Pharma PLC Annual Data

Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda 0.000.000.000.000.00-0.69-1.21-15.9267.6219.34

Horizon Pharma PLC Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
ev2ebitda -15.92-104.06511.09-696.4367.6284.25140.4026.4419.3417.57
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK